<p>Gabelli Funds LLC 在最近向证券交易委员会提交的 13F 文件中表示，在第四季度将其在 ICU Medical, Inc. (NASDAQ:ICUI - 免费报告) 的股份减少了 13.2%。该机构投资者在此期间出售了 10,400 股后，持有 68,600 股该医疗器械供应商的股票。截至其最近的 SEC 文件，Gabelli Funds LLC 持有约 0.28% 的 ICU Medical，价值 9,787,000 美元。</p>
<p>其他大型投资者也买卖了该公司的股票。Covestor Ltd 在第三季度将其在 ICU Medical 的股份增加了 70.7%。Covestor Ltd 目前拥有 570 股该医疗器械供应商的股票，价值 68,000 美元，此前在上个季度又增购了 236 股。Strs Ohio 在第四季度将其在 ICU Medical 的股份增加了 60.0%。Strs Ohio 目前拥有 800 股该医疗器械供应商的股票，价值 114,000 美元，此前在此期间又购买了 300 股。Smartleaf Asset Management LLC 在第二季度将其在 ICU Medical 的股份增加了 11.6%。Smartleaf Asset Management LLC 目前拥有 969 股该医疗器械供应商的股票，价值 128,000 美元，此前在此期间又购买了 101 股。Headlands Technologies LLC 在第二季度购买了 ICU Medical 的新股份，价值 177,000 美元。最后，Allegheny Financial Group 在第四季度购买了 ICU Medical 的新股份，价值 214,000 美元。目前，96.10% 的股票由机构投资者持有。</p>
<h2>ICU Medical 股票上涨 0.5%</h2>
<p>ICUI 股票周三开盘价为 123.66 美元。该公司的速动比率为 1.17，流动比率为 2.34，债务与股本比率为 0.60。该公司的市值为 30.9 亿美元，市盈率为 66.84，市盈增长比率为 1.77，贝塔值为 0.74。ICU Medical, Inc. 的 12 个月最低价为 107.00 美元，最高价为 160.29 美元。该股票的 50 天简单移动平均线为 125.48 美元，200 天简单移动平均线为 138.48 美元。</p>
<p>ICU Medical (NASDAQ:ICUI - 获取免费报告) 最近一次发布财报是在 5 月 7 日星期四。该医疗器械供应商报告该季度每股收益为 1.97 美元，超出分析师一致预期的 1.78 美元，超出幅度为 0.19 美元。该季度的营业收入为 5.2577 亿美元，而分析师预期为 5.2065 亿美元。ICU Medical 的股本回报率为 7.50%，净利润率为 2.15%。与去年同期相比，该公司的季度收入下降了 12.3%。在去年同期，该公司每股收益为 1.72 美元。ICU Medical 已将其 2026 财年的指导目标设定为每股收益 7.750-8.450 美元。平均而言，股票分析师预测 ICU Medical, Inc. 本财年将发布每股收益 6.31 美元。</p>
<h2>分析师评级上调与下调</h2>
<p>ICUI 最近成为多份分析师报告的主题。Weiss Ratings 在 5 月 11 日星期一的研究报告中将 ICU Medical 的评级从 &#34;卖出 (d)&#34; 上调至 &#34;卖出 (d+)&#34;。Piper Sandler 在 4 月 17 日星期五的研究报告中将 ICU Medical 的目标价从 178.00 美元下调至 163.00 美元，并对该股票给予 &#34;增持&#34; 评级。KeyCorp 在 4 月 27 日星期一的研究报告中将 ICU Medical 的目标价从 180.00 美元下调至 164.00 美元，并对该股票给予 &#34;增持&#34; 评级。Jefferies Financial Group 在 5 月 7 日星期四的研究报告中将 ICU Medical 的评级上调至 &#34;强力买入&#34;。最后，Wall Street Zen 在 5 月 9 日星期六的研究报告中将 ICU Medical 的评级从 &#34;持有&#34; 上调至 &#34;买入&#34;。两位研究分析师对该股票给予 &#34;强力买入&#34; 评级，两位给予 &#34;买入&#34; 评级，一位对该公司给予 &#34;卖出&#34; 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 &#34;买入&#34;，共识目标价为 169.00 美元。</p>
<p><strong>获取我们最新的 ICU Medical 股票分析</strong></p>
<h2>ICU Medical 的内部交易</h2>
<p>在其他 ICU Medical 新闻中，董事 David C. Greenberg 于 5 月 12 日星期二出售了 2,424 股 ICU Medical 股票。该股票的平均售价为 122.91 美元，总交易额为 297,933.84 美元。交易完成后，该董事持有 7,960 股公司股票，价值 978,363.60 美元。此次交易使其持股减少了 23.34%。该交易已在向证券交易委员会的文件中披露，相关信息可通过此链接获取。此外，副总裁 Virginia Ruth Sanzone 于 5 月 14 日星期四出售了 2,447 股 ICU Medical 股票。该股票的平均售价为 124.08 美元，总价值为 303,623.76 美元。交易完成后，该副总裁直接持有 19,460 股公司股票，价值 2,414,596.80 美元。此次交易使其持股减少了 11.17%。有关此次出售的更多细节可在官方 SEC 披露中找到。2.10% 的股票由内部人士持有。</p>
<h2>ICU Medical 公司简介</h2>
<p>(免费报告)</p>
<p>ICU Medical, Inc. 及其子公司开发、制造和销售用于输液治疗、血管通路和生命监护应用的医疗设备。其输液治疗产品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的无针产品；Neutron 导管通畅设备；ChemoClave 和 ChemoLock 封闭系统转移设备，用于限制有害药物或蒸汽浓度的逸出，阻止环境污染物进入系统，并消除针刺伤害的风险；Tego 无针连接器；Deltec GRIPPER 非穿刺针用于门静脉通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 ICU Medical</li>
<li>HIVE 利用电力进行 AI 转型</li>
<li>深入分析 NVIDIA 最新的投资组合动态</li>
<li>Brady Corp 进行大规模 AI 驱动的突破</li>
<li>为什么 Home Depot 的抛售可能成为一个巨大的机会</li>
</ul>
<p><strong>想知道其他对 ICUI 感兴趣的对冲基金持有哪些股票吗？</strong> 请访问 HoldingsChannel.com，获取 ICU Medical, Inc.（NASDAQ:ICUI - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 ICU Medical 吗？</h2>
<p>在考虑 ICU Medical 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 ICU Medical 并不在名单上。</p>
<p>虽然 ICU Medical 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

ICU医疗

<p>Gabelli Funds LLC 在 ICU Medical, Inc. 的持股减少了 13.2%，在第四季度出售了 10,400 股，目前持有 68,600 股，价值约 979 万美元。其他投资者，包括 Covestor Ltd 和 Strs Ohio，增加了他们的持股。ICU Medical 的股票开盘价为 123.66 美元，市值为 30.9 亿美元。该公司报告第一季度每股收益为 1.97 美元，超出预期，但收入同比下降了 12.3%。分析师的评级各异，普遍持 “买入” 评级，目标价为 169.00 美元</p>

<p>Gabelli Funds LLC cut its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 13.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,600 shares of the medical instruments supplier's stock after selling 10,400 shares during the period. Gabelli Funds LLC owned about 0.28% of ICU Medical worth $9,787,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Gabelli Funds LLC 在最近向证券交易委员会提交的 13F 文件中表示，在第四季度将其在 ICU Medical, Inc. (NASDAQ:ICUI - 免费报告) 的股份减少了 13.2%。该机构投资者在此期间出售了 10,400 股后，持有 68,600 股该医疗器械供应商的股票。截至其最近的 SEC 文件，Gabelli Funds LLC 持有约 0.28% 的 ICU Medical，价值 9,787,000 美元。</p>
</div><p>Other large investors have also bought and sold shares of the company. Covestor Ltd lifted its stake in ICU Medical by 70.7% during the 3rd quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier's stock valued at $68,000 after acquiring an additional 236 shares in the last quarter. Strs Ohio raised its stake in shares of ICU Medical by 60.0% during the 4th quarter. Strs Ohio now owns 800 shares of the medical instruments supplier's stock worth $114,000 after purchasing an additional 300 shares during the period. Smartleaf Asset Management LLC raised its stake in shares of ICU Medical by 11.6% during the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier's stock worth $128,000 after purchasing an additional 101 shares during the period. Headlands Technologies LLC bought a new stake in shares of ICU Medical during the 2nd quarter worth $177,000. Finally, Allegheny Financial Group bought a new stake in shares of ICU Medical during the 4th quarter worth $214,000. 96.10% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他大型投资者也买卖了该公司的股票。Covestor Ltd 在第三季度将其在 ICU Medical 的股份增加了 70.7%。Covestor Ltd 目前拥有 570 股该医疗器械供应商的股票，价值 68,000 美元，此前在上个季度又增购了 236 股。Strs Ohio 在第四季度将其在 ICU Medical 的股份增加了 60.0%。Strs Ohio 目前拥有 800 股该医疗器械供应商的股票，价值 114,000 美元，此前在此期间又购买了 300 股。Smartleaf Asset Management LLC 在第二季度将其在 ICU Medical 的股份增加了 11.6%。Smartleaf Asset Management LLC 目前拥有 969 股该医疗器械供应商的股票，价值 128,000 美元，此前在此期间又购买了 101 股。Headlands Technologies LLC 在第二季度购买了 ICU Medical 的新股份，价值 177,000 美元。最后，Allegheny Financial Group 在第四季度购买了 ICU Medical 的新股份，价值 214,000 美元。目前，96.10% 的股票由机构投资者持有。</p>
</div><h2>ICU Medical Stock Up 0.5%</h2>
<div class="lb-trans"><h2>ICU Medical 股票上涨 0.5%</h2>
</div><p>ICUI stock opened at $123.66 on Wednesday. The company has a quick ratio of 1.17, a current ratio of 2.34 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $3.09 billion, a PE ratio of 66.84, a PEG ratio of 1.77 and a beta of 0.74. ICU Medical, Inc. has a twelve month low of $107.00 and a twelve month high of $160.29. The stock has a 50-day simple moving average of $125.48 and a two-hundred day simple moving average of $138.48.</p>
<div class="lb-trans"><p>ICUI 股票周三开盘价为 123.66 美元。该公司的速动比率为 1.17，流动比率为 2.34，债务与股本比率为 0.60。该公司的市值为 30.9 亿美元，市盈率为 66.84，市盈增长比率为 1.77，贝塔值为 0.74。ICU Medical, Inc. 的 12 个月最低价为 107.00 美元，最高价为 160.29 美元。该股票的 50 天简单移动平均线为 125.48 美元，200 天简单移动平均线为 138.48 美元。</p>
</div><p>ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share for the quarter, beating analysts' consensus estimates of $1.78 by $0.19. The business had revenue of $525.77 million during the quarter, compared to analyst estimates of $520.65 million. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The company's quarterly revenue was down 12.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.72 EPS. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, equities analysts predict that ICU Medical, Inc. will post 6.31 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>ICU Medical (NASDAQ:ICUI - 获取免费报告) 最近一次发布财报是在 5 月 7 日星期四。该医疗器械供应商报告该季度每股收益为 1.97 美元，超出分析师一致预期的 1.78 美元，超出幅度为 0.19 美元。该季度的营业收入为 5.2577 亿美元，而分析师预期为 5.2065 亿美元。ICU Medical 的股本回报率为 7.50%，净利润率为 2.15%。与去年同期相比，该公司的季度收入下降了 12.3%。在去年同期，该公司每股收益为 1.72 美元。ICU Medical 已将其 2026 财年的指导目标设定为每股收益 7.750-8.450 美元。平均而言，股票分析师预测 ICU Medical, Inc. 本财年将发布每股收益 6.31 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><p>ICUI has been the topic of a number of recent analyst reports. Weiss Ratings upgraded ICU Medical from a &#34;sell (d)&#34; rating to a &#34;sell (d+)&#34; rating in a research note on Monday, May 11th. Piper Sandler lowered their target price on ICU Medical from $178.00 to $163.00 and set an &#34;overweight&#34; rating on the stock in a research note on Friday, April 17th. KeyCorp lowered their target price on ICU Medical from $180.00 to $164.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday, April 27th. Jefferies Financial Group upgraded ICU Medical to a &#34;strong-buy&#34; rating in a research note on Thursday, May 7th. Finally, Wall Street Zen upgraded ICU Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, May 9th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of &#34;Buy&#34; and a consensus target price of $169.00.</p>
<div class="lb-trans"><p>ICUI 最近成为多份分析师报告的主题。Weiss Ratings 在 5 月 11 日星期一的研究报告中将 ICU Medical 的评级从 &#34;卖出 (d)&#34; 上调至 &#34;卖出 (d+)&#34;。Piper Sandler 在 4 月 17 日星期五的研究报告中将 ICU Medical 的目标价从 178.00 美元下调至 163.00 美元，并对该股票给予 &#34;增持&#34; 评级。KeyCorp 在 4 月 27 日星期一的研究报告中将 ICU Medical 的目标价从 180.00 美元下调至 164.00 美元，并对该股票给予 &#34;增持&#34; 评级。Jefferies Financial Group 在 5 月 7 日星期四的研究报告中将 ICU Medical 的评级上调至 &#34;强力买入&#34;。最后，Wall Street Zen 在 5 月 9 日星期六的研究报告中将 ICU Medical 的评级从 &#34;持有&#34; 上调至 &#34;买入&#34;。两位研究分析师对该股票给予 &#34;强力买入&#34; 评级，两位给予 &#34;买入&#34; 评级，一位对该公司给予 &#34;卖出&#34; 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 &#34;买入&#34;，共识目标价为 169.00 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on ICU Medical</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 ICU Medical 股票分析</strong></p>
</div><h2>Insider Transactions at ICU Medical</h2>
<div class="lb-trans"><h2>ICU Medical 的内部交易</h2>
</div><p>In other ICU Medical news, Director David C. Greenberg sold 2,424 shares of ICU Medical stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total transaction of $297,933.84. Following the completion of the transaction, the director owned 7,960 shares of the company's stock, valued at $978,363.60. The trade was a 23.34% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this link. Also, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $124.08, for a total value of $303,623.76. Following the transaction, the vice president directly owned 19,460 shares of the company's stock, valued at $2,414,596.80. The trade was a 11.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 2.10% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他 ICU Medical 新闻中，董事 David C. Greenberg 于 5 月 12 日星期二出售了 2,424 股 ICU Medical 股票。该股票的平均售价为 122.91 美元，总交易额为 297,933.84 美元。交易完成后，该董事持有 7,960 股公司股票，价值 978,363.60 美元。此次交易使其持股减少了 23.34%。该交易已在向证券交易委员会的文件中披露，相关信息可通过此链接获取。此外，副总裁 Virginia Ruth Sanzone 于 5 月 14 日星期四出售了 2,447 股 ICU Medical 股票。该股票的平均售价为 124.08 美元，总价值为 303,623.76 美元。交易完成后，该副总裁直接持有 19,460 股公司股票，价值 2,414,596.80 美元。此次交易使其持股减少了 11.17%。有关此次出售的更多细节可在官方 SEC 披露中找到。2.10% 的股票由内部人士持有。</p>
</div><h2>ICU Medical Profile</h2>
<div class="lb-trans"><h2>ICU Medical 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.</p>
<div class="lb-trans"><p>ICU Medical, Inc. 及其子公司开发、制造和销售用于输液治疗、血管通路和生命监护应用的医疗设备。其输液治疗产品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的无针产品；Neutron 导管通畅设备；ChemoClave 和 ChemoLock 封闭系统转移设备，用于限制有害药物或蒸汽浓度的逸出，阻止环境污染物进入系统，并消除针刺伤害的风险；Tego 无针连接器；Deltec GRIPPER 非穿刺针用于门静脉通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than ICU Medical</li>
<li>HIVE Weaponizes Power for an AI Pivot</li>
<li>A Deep Dive Into NVIDIA’s Latest Portfolio Moves</li>
<li>Brady Corp Wires Up a Massive AI-Powered Breakout</li>
<li>Why Home Depot’s Sell-Off Could Become a Huge Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 ICU Medical</li>
<li>HIVE 利用电力进行 AI 转型</li>
<li>深入分析 NVIDIA 最新的投资组合动态</li>
<li>Brady Corp 进行大规模 AI 驱动的突破</li>
<li>为什么 Home Depot 的抛售可能成为一个巨大的机会</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ICUI?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对 ICUI 感兴趣的对冲基金持有哪些股票吗？</strong> 请访问 HoldingsChannel.com，获取 ICU Medical, Inc.（NASDAQ:ICUI - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ICUI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in ICU Medical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 ICU Medical 吗？</h2>
</div><p>Before you consider ICU Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 ICU Medical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 ICU Medical 并不在名单上。</p>
</div><p>While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 ICU Medical 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Gabelli Funds LLC Sells 10,400 Shares of ICU Medical, Inc. $ICUI

Market Beat

Piper Sandler Cos

Gabelli Funds LLC 出售了 10,400 股 ICU 医疗公司（ICU Medical, Inc.）的股票，股票代码为$ICUI